ABSTRACT
The goal of this chapter is to describe strategies for the development of RNA-and DNA-based therapies for Huntington’s disease (HD). RNA-based therapies use endogenous cellular mechanisms for the suppression of gene expression and have
Introduction ............................................................................................................225 HD Therapeutics Based on Antisense Technologies ..............................................226
